This report provides exclusive insights into the COVID-19 impact on the Vibrating Mesh Nebulizer Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Vibrating Mesh Nebulizer Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Vibrating Mesh Nebulizer Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on vibrating mesh nebulizer market provides an in-depth analysis of segments and sub-segments in the global as well as regional vibrating mesh nebulizer market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional vibrating mesh nebulizer market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global vibrating mesh nebulizer market. According to the report, the global vibrating mesh nebulizer market is projected to grow at a CAGR of 7.6% over the forecast period of 2018-2024.
A nebulizer is a drug delivery device used to deliver medication in the form of a mist inhaled into the lungs. Nebulizer breaks up medical solutions into small aerosol droplets and delivers them directly to the patient’s airways for respiratory therapy. Vibrating mesh nebulizer is a type of nebulizer. Vibrating mesh nebulizer (VMN) which is very user-friendly and is more efficient. It has extremely low residual volume. It is effectively used for the administration of inhaled antibiotics, corticosteroids, and other drugs. Vibrating mesh technology is one of the most efficient technologies used for the nebulizer.
The increasing prevalence of respiratory disorder such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, obstructive lung disorders in both the adult and pediatric populations over the globe is escalating the growth of vibrating mesh nebulizer market. Asthma kills approximately 1000 people every day and affects as many as 339 million people and occurrence is rising. Asthma is one of the common chronic breathing diseases. Additionally, WHO predicts that COPD will become the third leading cause of death worldwide by 2030. Furthermore, vibrating mesh nebulizer offers significant advantages over the systemic drug delivery including reduced incidence of side effects, ease of use for all ages, very quiet during operation, relative ease of self-administration by patients and combine medications, as well as control dosage. Additionally, it can be used at home, clinic, hospital and during travel. Growing awareness regarding the vibrating mesh nebulizer among the people contributes to the growth of this market. Moreover, increasing air pollution across the globe and the growing geriatric population with respiratory diseases are supporting factors responsible for the growth of the vibrating mesh nebulizer market. On the other hand, the risk of drug loss caused by nebulizer during the conversion of the drug into the mist is one of the major concern could hamper the growth vibrating mesh nebulizer market. Furthermore, increasing adoption of the nebulizer and growing consumer spending on healthcare activities are providing the growth of vibrating mesh nebulizer market in coming years.
North America accounted to be the largest share in the global vibrating mesh nebulizer market. High prevalence of COPD and asthma in adults and children’s boost the demand of vibrating mesh nebulizer in the U.S. Additionally, well-developed healthcare infrastructures and technological advancement in North America region contributes to the growth of this market. Moreover, raising awareness regarding the use of nebulizers, higher demand for quality health products and growing adoption of nebulizer devices have a positive impact on the growth of the market. Europe is expected to witness substantial growth in the vibrating mesh nebulizer market in the near future. The Asia-Pacific is expected to be the fastest growing region during the forecast period. Growing geriatric population coupled with high cases of the respiratory disorder is the main factor responsible for the growth of vibrating mesh nebulizer market.
The report on global vibrating mesh nebulizer market covers segments such as end-users. On the basis of end-users, the sub-markets include clinics, hospitals, emergency medical centers, and homecare.
The report provides profiles of the companies in the market such as PARI GmbH, OMRON Corporation, Jiangsu Yuyue Medical Instruments Co., Ltd., Koninklijke Philips N.V., Vectura Group Plc, Health & Life Co., Ltd., HCmed Innovations Co., Ltd., Aerogen, and Philips Healthcare.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of vibrating mesh nebulizer market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.